ANI Pharmaceuticals
Baudette
About ANI Pharmaceuticals
ANI Pharmaceuticals is a specialty pharmaceuticals industry that develops, manufactures and markets top-quality prescription pharmaceuticals, made in the U.S.A. ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $500K – $1M
- Total funding: $581.8M
- Funding stage: M&A
- Last round: Post-IPO Debt (Aug 2024)
- Ticker: nasdaq:ANIP
- Website: anipharmaceuticals.com
- Phone: (218)634-3500
Industries & Categories
Biotechnology, Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ani-pharmaceuticals-52695 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.